abstract Background: Because primary aldosteronism is not uncommon, specifically
treatable and in some cases curable, and carries higher risks for cardiovascular morbidity …

Widespread application of the plasma aldosterone/renin ratio (ARR) as a screening test has
led to the recognition that primary aldosteronism (PA) is the most common specifically …

Objectives Due to the widespread use of the aldosterone to renin ratio (ARR), primary
aldosteronism is currently recognized as a frequent cause of secondary hypertension. After …

Primary aldosteronism is increasingly investigated in hypertension being associated with an
elevated cardiovascular risk. Aldosterone has been reported to increase in the luteal phase …

Background: The ratio of plasma aldosterone concentration to plasma renin activity (PRA) is
considered the screening test of choice for primary aldosteronism. Uncertainty exists …

Context Primary aldosteronism (PA) screening relies on an elevated aldosterone to renin
ratio with a minimum aldosterone level, which varies from 10 to 15 ng/dL (277-415.5 pmol/L) …

Background As renin and aldosterone levels vary during the menstrual cycle, and are critical
criteria for interpretation of aldosterone suppression tests to confirm or exclude primary …

Background: The value of the ratio of plasma aldosterone concentration (aldosterone) to
plasma renin activity (renin) to identify patients at risk for primary aldosteronism is …

Although the aldosterone/renin ratio (ARR) is the most reliable screening test for primary
aldosteronism, false positives and negatives occur. Dietary salt restriction, concomitant …

Objective. We conducted a systematic review of the literature to establish the test
characteristics (sensitivity, specificity, likelihood ratios at different cutoff values) of the …